vs
ARVINAS, INC.（ARVN）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是ARVINAS, INC.的1.7倍（$71.1M vs $41.9M），RE/MAX Holdings, Inc.净利率更高（2.0% vs -83.8%，领先85.8%），RE/MAX Holdings, Inc.同比增速更快（-1.8% vs -59.1%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $-59.2M），过去两年ARVINAS, INC.的营收复合增速更高（10.0% vs -4.7%）
Arvinas是一家临床阶段生物技术企业，专注开发PROTAC靶向蛋白降解类疗法，用于治疗癌症及罕见病，核心管线覆盖多个存在未满足医疗需求的适应症，主要面向美国及全球生物制药市场运营。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
ARVN vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.7倍
$41.9M
营收增速更快
RMAX
高出57.2%
-59.1%
净利率更高
RMAX
高出85.8%
-83.8%
自由现金流更多
RMAX
多$92.7M
$-59.2M
两年增速更快
ARVN
近两年复合增速
-4.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.9M | $71.1M |
| 净利润 | $-35.1M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -104.5% | 13.1% |
| 净利率 | -83.8% | 2.0% |
| 营收同比 | -59.1% | -1.8% |
| 净利润同比 | 28.7% | -75.2% |
| 每股收益（稀释后） | $-0.48 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARVNRMAX
| Q4 25 | — | $71.1M | ||
| Q3 25 | $41.9M | $73.2M | ||
| Q2 25 | — | $72.8M | ||
| Q1 25 | $188.8M | $74.5M | ||
| Q4 24 | $59.2M | $72.5M | ||
| Q3 24 | $102.4M | $78.5M | ||
| Q2 24 | $76.5M | $78.5M | ||
| Q1 24 | $25.3M | $78.3M |
净利润ARVNRMAX
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-35.1M | $4.0M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | $82.9M | $-2.0M | ||
| Q4 24 | $-45.1M | $5.8M | ||
| Q3 24 | $-49.2M | $966.0K | ||
| Q2 24 | $-35.2M | $3.7M | ||
| Q1 24 | $-69.4M | $-3.4M |
营业利润率ARVNRMAX
| Q4 25 | — | 13.1% | ||
| Q3 25 | -104.5% | 25.0% | ||
| Q2 25 | — | 19.3% | ||
| Q1 25 | 37.8% | 7.2% | ||
| Q4 24 | -98.1% | 5.9% | ||
| Q3 24 | -58.9% | 19.4% | ||
| Q2 24 | -63.4% | 20.6% | ||
| Q1 24 | -329.2% | 5.8% |
净利率ARVNRMAX
| Q4 25 | — | 2.0% | ||
| Q3 25 | -83.8% | 5.4% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | 43.9% | -2.6% | ||
| Q4 24 | -76.2% | 8.0% | ||
| Q3 24 | -48.0% | 1.2% | ||
| Q2 24 | -46.0% | 4.7% | ||
| Q1 24 | -274.3% | -4.3% |
每股收益（稀释后）ARVNRMAX
| Q4 25 | — | — | ||
| Q3 25 | $-0.48 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.14 | — | ||
| Q4 24 | $-0.63 | — | ||
| Q3 24 | $-0.68 | — | ||
| Q2 24 | $-0.49 | — | ||
| Q1 24 | $-0.97 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $787.6M | $118.7M |
| 总债务越低越好 | $600.0K | $432.2M |
| 股东权益账面价值 | $564.4M | $452.4M |
| 总资产 | $844.3M | $582.5M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资ARVNRMAX
| Q4 25 | — | $118.7M | ||
| Q3 25 | $787.6M | $107.5M | ||
| Q2 25 | — | $94.3M | ||
| Q1 25 | $954.3M | $89.1M | ||
| Q4 24 | $1.0B | $96.6M | ||
| Q3 24 | $1.1B | $83.8M | ||
| Q2 24 | $1.2B | $66.1M | ||
| Q1 24 | $1.2B | $82.1M |
总债务ARVNRMAX
| Q4 25 | — | $432.2M | ||
| Q3 25 | $600.0K | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | $700.0K | $435.3M | ||
| Q4 24 | $800.0K | $436.2M | ||
| Q3 24 | $800.0K | $437.2M | ||
| Q2 24 | $900.0K | $438.1M | ||
| Q1 24 | $900.0K | $439.0M |
股东权益ARVNRMAX
| Q4 25 | — | $452.4M | ||
| Q3 25 | $564.4M | $448.1M | ||
| Q2 25 | — | $442.4M | ||
| Q1 25 | $660.1M | $433.5M | ||
| Q4 24 | $561.7M | $429.5M | ||
| Q3 24 | $586.0M | $423.1M | ||
| Q2 24 | $600.2M | $418.4M | ||
| Q1 24 | $609.7M | $412.0M |
总资产ARVNRMAX
| Q4 25 | — | $582.5M | ||
| Q3 25 | $844.3M | $582.2M | ||
| Q2 25 | — | $574.8M | ||
| Q1 25 | $1.0B | $571.4M | ||
| Q4 24 | $1.1B | $581.6M | ||
| Q3 24 | $1.2B | $578.6M | ||
| Q2 24 | $1.3B | $571.4M | ||
| Q1 24 | $1.2B | $566.7M |
负债/权益比ARVNRMAX
| Q4 25 | — | 0.96× | ||
| Q3 25 | 0.00× | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | 0.00× | 1.00× | ||
| Q4 24 | 0.00× | 1.02× | ||
| Q3 24 | 0.00× | 1.03× | ||
| Q2 24 | 0.00× | 1.05× | ||
| Q1 24 | 0.00× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-59.1M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $-59.2M | $33.5M |
| 自由现金流率自由现金流/营收 | -141.3% | 47.1% |
| 资本支出强度资本支出/营收 | 0.2% | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $-361.6M | $56.8M |
8季度趋势，按日历期对齐
经营现金流ARVNRMAX
| Q4 25 | — | $40.9M | ||
| Q3 25 | $-59.1M | $17.7M | ||
| Q2 25 | — | $4.6M | ||
| Q1 25 | $-88.9M | $5.7M | ||
| Q4 24 | $-84.1M | $59.7M | ||
| Q3 24 | $-128.0M | $17.6M | ||
| Q2 24 | $50.3M | $15.9M | ||
| Q1 24 | $-97.5M | $9.4M |
自由现金流ARVNRMAX
| Q4 25 | — | $33.5M | ||
| Q3 25 | $-59.2M | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | $-89.3M | $4.0M | ||
| Q4 24 | $-84.4M | $53.0M | ||
| Q3 24 | $-128.7M | $16.3M | ||
| Q2 24 | $49.6M | $14.0M | ||
| Q1 24 | $-97.6M | $6.8M |
自由现金流率ARVNRMAX
| Q4 25 | — | 47.1% | ||
| Q3 25 | -141.3% | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | -47.3% | 5.3% | ||
| Q4 24 | -142.6% | 73.2% | ||
| Q3 24 | -125.7% | 20.8% | ||
| Q2 24 | 64.8% | 17.8% | ||
| Q1 24 | -385.8% | 8.6% |
资本支出强度ARVNRMAX
| Q4 25 | — | 10.4% | ||
| Q3 25 | 0.2% | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | 0.2% | 2.3% | ||
| Q4 24 | 0.5% | 9.1% | ||
| Q3 24 | 0.7% | 1.7% | ||
| Q2 24 | 0.9% | 2.4% | ||
| Q1 24 | 0.4% | 3.3% |
现金转化率ARVNRMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | -1.07× | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARVN
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
